AEG-33783

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameAEG-33783

Drug Alias NameAEG-33783

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of Actionc-Jun N-terminal kinase inhibitorsHeat shock 70 kDa protein 1 stimulants

Targetsc-Jun N-terminal kinaseHeat shock 70 kDa protein 1

Therapy Area/IndicationsDiabetic NeuropathiesPeripheral Nervous System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPharmascience Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPharmascience Inc

Active IndicationsN/A

Inactive IndicationsDiabetic NeuropathiesPeripheral Nervous System Diseases

ATC CodeN/A